• Discounts and special offers
  • Subscriber-only articles and interviews
  • Breaking news and trending topics

Already a subscriber?

By signing up, you accept Moneywise's Terms of Use, Subscription Agreement, and Privacy Policy.

Not interested ?

The short version

  • Femtech refers to any technology product or service that supports women’s health, including fertility care, pregnancy and postpartum care, hormonal disorders, and more.
  • Some of the top femtech startups include Ava, Bloomlife, Kindbody, Flo, Marani Health, Renovia, Carrot Fertility, and LactApp.
  • Investing in femtech gives investors the opportunity to support a previously underserved demographic in the technology industry.
  • The femtech industry has seen massive growth over the past several years and is expected to grow even more exponentially in the coming years.

Discover how a simple decision today could lead to an extra $1.3 million in retirement

Learn how you can set yourself up for a more prosperous future by exploring why so many people who work with financial advisors retire with more wealth.

Discover the full story and see how you could be on the path to an extra $1.3 million in retirement.

Read More

What is FemTech?

Femtech — short for female technology — refers to any product that’s designed to support women’s health. These products can come in the form of websites, apps, services, and software.

Femtech products and services usually fall into one of several categories:

  • Menstruation and period care
  • Birth control and fertility
  • Pregnancy and postpartum health
  • Breastfeeding
  • Menopause
  • Hormonal disorders and chronic conditions
  • Pelvic health
  • Sexual wellness
  • General women’s health

The term “femtech” was coined by entrepreneur Ida Tin in 2016. The industry has been growing exponentially since then, and it doesn’t appear to be slowing down. For example, femtech funding in 2021 reached roughly $2.5 billion, an increase of 300% from the previous year.

In addition to being designed for women, these products are also usually designed by women. More than 70% of femtech companies have at least one female founder, which is significantly higher than other technology companies (or other companies in general).

The best FemTech startups

The best femtech startups
Startup Product Country/State Of Origin
Ava Fertility tracking bracelet Zurich, Switzerland
Bloomlife Prenatal tracking app Genk, Belgium
Carrot Fertility Employer-sponsored fertility benefits San Francisco
Flo Period and ovulation tracker Belarus
Marani Health Remote prenatal monitoring Minneapolis
Renovia Pelvic Floor therapy devices Boston
Kindbody Employer-sponsored fertility benefits and wellness clinic New York
Lactapp Lactation support app Spain

1. Ava

Ava is a fertility tracking bracelet that claims to have helped 70,000 women and birthing people conceive. It was created by Swiss entrepreneurs Lea von Bidder, Philipp Tholen, Peter Stein and Pascal Koenig in 2014. Since then, the company has grown to a 70 employees worldwide. It is the first FDA-approved fertility tracker, backing hard clinical science with the power of AI.

FDA-approved fertility tracker
Source: Ava

As of 2022, the company has received more than $42 million in funding over six funding rounds, the most recent being a Series B funding round in May 2018. In 2021, Ava began tiptoeing past the realm of strictly FemTech by running promising clinical trials on the bracelet's ability to detect asymptomatic signs of COVID-19 for all users.

2. Bloomlife

Bloomlife is a femtech company that uses remote monitoring to help guide pregnant people and offer real-time, personalized insights through their perinatal period. Their mission is to reduce the number of pregnancy-related deaths and maternal mortality rates in the U.S and beyond.

Founded in January 2014 by Eric Dy and Julien Penders, the San Francisco-based company has raised more than $14.6 million over eight funding rounds. The company has major investors such as Johnson & Johnson and the National Science Foundation.

3. Carrot Fertility

Carrot Fertility helps employers offer flexible, transparent, and cost-conscious fertility benefits to their employers. They specialize in egg-freezing and IVF treatments by working directly with employers to deliver employee benefit programs. They seek to broaden accessibility to fertility care, lower costs, and destigmatize the conversation around fertility and wellness in the corporate world.

Carrot Fertility was founded in 2015 in San Francisco by Arun Venkatesan, Asima Ahmad, Juli Insinger, and Tammy Sun. The company has raised more than $114 million across seven funding rounds, the latest of which was a Series C funding round in August 2021.

4. Flo

Flo is an AI-powered women’s health app that helps women track their periods and ovulation cycles. In addition, it also provides a content hub that allows women across the world to share data and information and learn from gynecological experts. The company hit a snag when the FTC launched a complaint against them for sharing the data of millions of users to third-party companies like Facebook and Google; this launched a wave of negative criticism.

Flo is an AI-powered women’s health app that helps women track their periods and ovulation cycles
Source: Flo

However, the company has since rolled out new privacy features, including an Anonymous Mode which allows women to track their data without having to share identifying information such as their names or email addresses.

Flo was founded in 2016 by Andrew Kovzel, Dmitry Gurski, Max Scrobov, and Yuri Gurski. It’s a sub-organization of the health and well-being technology company Palta. The company has raised more than $75.5 million in funding across five funding rounds. When it launched, their initial valuation was $200 million. The latest funding came from a Series B round in September 2021.

5. Marani Health

Marani Health is an AI-enabled prenatal care monitoring platform for use in clinics and at home for remote monitoring. Founded by specialists from the Mayo Clinic, Marani Health doesn’t just monitor pregnancy, it also aims to identify complications and medical issues related to pregnancy both before and in the postpartum stage.

Marani Health was founded in May 2018 by Ann Holder and is based in Minneapolis, Minnesota. It has raised nearly $13 million across three funding rounds. The latest funding round was its seed round that took place in November 2021.

6. Renovia

Renovia is a medical tech company that specifically creates therapeutic devices to treat and strengthen pelvic floor disorders. Urinary incontinence has long been a medically overlooked issue that affects over 12 million women in the U.S alone. Their system treats these issues through a combination of traditional therapies as well as non-surgical digital solutions such as a vaginal motion sensor and smartphone app.

Renovia is a medical tech company that specifically creates therapeutic devices to treat and strengthen pelvic floor disorders
Source: Renovia

Renovia was founded in Boston in 2016 by Marc Beer and Ramon Iglesias. In addition to receiving a “Breakthrough Device Designation” grant by the FDA, it has raised more than $72 million in funding across five rounds, the latest of which was a Series C funding round in April 2021.

7. Kindbody

Similar to Carrot Health, Kindbody offers employer-sponsored egg-freezing and IVF treatments, as well as adoption and surrogacy services. They’re both an insurance provider and a family of fertility and wellness clinics that offer broader support in gynecology and infertility treatments for all.

Kindbody was founded in 2018 by Gina Bartasi and Joanne Schneider and is based in New York. To date, the company has raised nearly $155 million across seven funding rounds, including a $10 million investment from Google Ventures. The latest funding round took place in May 2022, and is expected to go public next year.

More: Private vs. public companies: key differences to know

8. LactApp

LactApp is a mobile app that seeks to support breastfeeding mothers through personalized guidance and advice. Once users have had the opportunity to use the app, they can decide to pay for the services they received. In addition to their Pay-What-You-Can app, LactApp Medical helps healthcare professionals with expert training, consultation and tracking to improve their services.

LactApp was founded in Spain in 2016 by Alba Padro Arocas, Enric Pallares Roura, and Maria Berruezo. The company hasn’t yet gone through any major funding rounds, but is currently preparing for a Series A round. To date, it has seven private investors through venture capital.

Diversify your portfolio by investing in art

When it comes to investing, a diversified portfolio can lead to better returns. Masterworks' art investing platform has turned a previously inaccessible asset class into an actual option for individual investors. Think of artists like Banksy, Monet or Warhol. Get priority access and skip the waitlist here.

Skip the waitlist

Should you invest in FemTech?

Are you wondering whether you should be investing in femtech? There are a few different angles from which we can tackle this question.

First, investing in femtech is a way to support women — both the women who create these products and the women who use them.

Issues with breast-feeding, pelvic floor disorders and affordable access to fertility treatments are problems that billions of women around the world have struggled with for generations.

Yet it's only now that companies are starting to look for sophisticated solutions for them.

The fact is that women are historically underserved in the technology industry. First, while women make up about half of the population, they only fill about a quarter of technical roles in the information technology (IT) industry.

Additionally, fewer than 2% of enterprise software startups in the U.S. have female founders. And those that do  are less likely to get venture capital funding than companies founded by men.

More: Women and investing: Latest statistics

And just as women are underserved working in technology, they’re also often underserved by products. Issues with breast-feeding, pelvic floor disorders and affordable access to fertility treatments are ones that billions of women around the world have struggled with for generations. Yet it's only now that companies are starting to look for sophisticated solutions for them.

Politics aside, it’s also important to look at your decision of whether to invest in femtech from a financial perspective. At the end of the day, is it a good investment that’s going to make you money?

The numbers we've shared so far suggest that it probably is. Some femtech companies seeing triple-digit growth and funding rounds that amount to tens of millions of dollars. With a steadily growing and ever-empowered customer base to boot, this industry is positioned to grow even bigger in the coming years.

The takeaway: is Femtech a worthwhile investment?

The industry has seen massive growth over the past several years, and it doesn’t seem to be slowing down anytime soon. It’s no surprise: Just a quick glance through the list above, it’s clear that women and parents have been neglected for far too long. However, the tide is changing. Investors can help to broaden the accessibility of these services for all users, support female founders, all while seeing their returns grow.

Other emerging industries:

Sponsored

The richest 1% use an advisor. Do you?

Wealthy people know that having money is not the same as being good with money. WiserAdvisor can help you shape your financial future and connect with expert guidance. A trusted advisor helps you make smart choices about investments, retirement savings, and tax planning.

Erin Gobler Freelance Contributor

Erin Gobler is a freelance personal finance based in Madison, Wisconsin. After seven years working in state politics, she left to pursue writing full-time. Now she writes about financial topics including mortgages and investing.

Disclaimer

The content provided on Moneywise is information to help users become financially literate. It is neither tax nor legal advice, is not intended to be relied upon as a forecast, research or investment advice, and is not a recommendation, offer or solicitation to buy or sell any securities or to adopt any investment strategy. Tax, investment and all other decisions should be made, as appropriate, only with guidance from a qualified professional. We make no representation or warranty of any kind, either express or implied, with respect to the data provided, the timeliness thereof, the results to be obtained by the use thereof or any other matter. Advertisers are not responsible for the content of this site, including any editorials or reviews that may appear on this site. For complete and current information on any advertiser product, please visit their website.